Prompted by the evidence of the highly variable expression of KDM5C in GBM patients and hypothesizing that such heterogeneity might result in distinct tumor subtypes having peculiar tumorigenic features, we took advantage of public expression and methylation data available from The Cancer Genome Atlas (TCGA; GBM cohort). Here, KDM5C is linked to glioblastoma.